The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
Celebrus Technologies PLC - Middlesex, England-based data management platform, formerly known as D4t4 Solutions PLC - Says revenue in the six months to September 30 grew 60% to £13.0 million from £8.1 million the year before. Swings to pretax profit of £252,000 from a £1.1 million loss in the first half of financial 2023. Lifts interim dividend by 4.5% to 0.92 pence per share from 0.88p per share a year prior. Looking ahead, it says it is confident in achieving its full year market expectations of £32.1 million in revenue and £5.4 million in adjusted pretax profit. Chief Executive Officer Bill Bruno says: ‘Several key steps have been taken to further our strategy in the first half of the financial year. Not only have we delivered the expected results and continue to remain confident in our ability to meet market expectations for the full year, but we have continued to invest in Sales and Marketing and are seeing the positive effects in the form of building pipeline momentum... We continue to focus on driving ARR and our ability to build scalable, single-tenant, cloud-based environments for our Celebrus customers.’
----------
Aquila Services Group PLC - London-based management consultancy services provider - Says revenue in the first half of its financial year ending March 31 is unchanged year-on-year at £5.9 million. Pretax profit drops 69% to £93,000 from £302,000 the year before. Interim dividend remains unchanged YoY at 0.25p per share. Looking ahead, notes a positive outlook for the second half of the year.
----------
Concurrent Technologies PLC - Essex, England-based designer and manufacturer of computer boards -
Expects to deliver full-year revenue ahead of market expectations of £27 million. Says revenue for the six months to December 31 is expected to be ‘substantially higher’ than a year ago, due to the ‘strength of order intake over the preceding 24 months enabled by the significant investment in product development undertaken to facilitate new customers and design wins.’ CEO Miles Adcock says: ‘The performance of the team across the company has been exceptional throughout the year and, coupled with the continued easing of supply chains, we have seen revenue run rates almost double when compared to historical norms. Our success with design wins provides confidence that order intake moving forward will continue the current level of strong performance which will position us well to enjoy further growth through [2024] and beyond.
----------
San Leon Energy PLC - Nigeria-focused oil and gas production, development and exploration company -
Says it has not received payment of up to $187 million from Tri Ri Asset Management Corp. Says it continues to work with TRAM to ’understand the reasons for the delay and to enable funds to be released.‘ Previously confirmed that all conditions precedent to its investment have been satisfied, and requested draw down of the $125.0 million convertible secured loan. Says that Tri Ri Asset has confirmed that payment has been made.
----------
Lexington Gold Ltd - Signs deal with Discovery Drilling for 2,000 metre drill programme at the Bothaville project in Witwatersrand Gold Basin, South Africa. Expects drilling to start in mid-December. Chair Ed Nealon says: ’This initial drilling campaign is being undertaken on the very prospective Bothaville NE tenements located 70 km NE of the world-famous Welkom Goldfield. The target is the shallow A-Reef horizon which subcrops at a depth of only 250m. Previous drilling has indicated good grades for the A-Reef and at such a shallow depth this represents a viable target for the economic development of a Witwatersrand reef horizon. This is a very interesting start to Lexington’s campaign seeking to discover a new and viable gold reef horizon in a region of obvious gold mineralisation.‘
----------
TruSpine Technologies PLC - London Gatwick Airport-based medical device company - Continues to be in talks with the US Food & Drug Administration over its 510(k) application for Cervi-LOK. Last month, the FDA confirmed it had completed the technical screening of TruSpine’s 510(k) submission, which was submitted in late July, but sought further clarification on certain matters. The application was placed on technical screening hold ’until such time the relevant information requested has been provided to the FDA‘, adding that the submission could remain on hold until March 25 next year. Cervi-LOK is a screw free spinal stabilisation system.
----------
Copyright 2023 Alliance News Ltd. All Rights Reserved.
